Added to YB: 2026-07-22
Pitch date: 2026-03-07
LQDA [bullish]
Liquidia Corporation
+127.86%
current return
Author Info
Action This Day shares edgy, actionable ideas that can be implemented in a day. Sign up for the newsletter.
Company Info
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
Market Cap
$7.1B
Pitch Price
$35.50
Price Target
154.00 (+100%)
Dividend
N/A
EV/EBITDA
147.57
P/E
327.46
EV/Sales
24.55
Sector
Pharmaceuticals
Category
special_situation
What Actually Matters : Liquidia (LQDA)
LQDA: Up 100%+ in past year but still undervalued. Now profitable & on market. Awaiting single final litigation hurdle before becoming a derisked, simplified takeover target at ~2x today's price. Author in constant contact w/ mgmt; offered capital but co doesn't need it.
Read full article (1 min)